142 related articles for article (PubMed ID: 29409686)
1. LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model.
Tsukahara R; Yamamoto S; Yoshikawa K; Gotoh M; Tsukahara T; Neyama H; Ishii S; Akahoshi N; Yanagida K; Sumida H; Araki M; Araki K; Yamamura KI; Murakami-Murofushi K; Ueda H
J Pharmacol Sci; 2018 Feb; 136(2):93-96. PubMed ID: 29409686
[TBL] [Abstract][Full Text] [Related]
2. Analgesic effects of novel lysophosphatidic acid receptor 5 antagonist AS2717638 in rodents.
Murai N; Hiyama H; Kiso T; Sekizawa T; Watabiki T; Oka H; Aoki T
Neuropharmacology; 2017 Nov; 126():97-107. PubMed ID: 28859883
[TBL] [Abstract][Full Text] [Related]
3. Involvement of LPA1 receptor signaling in cerebral ischemia-induced neuropathic pain.
Halder SK; Yano R; Chun J; Ueda H
Neuroscience; 2013 Apr; 235():10-5. PubMed ID: 23318243
[TBL] [Abstract][Full Text] [Related]
4. Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain.
Lin ME; Rivera RR; Chun J
J Biol Chem; 2012 May; 287(21):17608-17617. PubMed ID: 22461625
[TBL] [Abstract][Full Text] [Related]
5. Lysophosphatidic acid-induced itch is mediated by signalling of LPA
Kittaka H; Uchida K; Fukuta N; Tominaga M
J Physiol; 2017 Apr; 595(8):2681-2698. PubMed ID: 28176353
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice.
Uchida H; Nagai J; Ueda H
Mol Pain; 2014 Nov; 10():71. PubMed ID: 25411045
[TBL] [Abstract][Full Text] [Related]
7. Lysophosphatidic acid receptors (LPARs): Potential targets for the treatment of neuropathic pain.
Velasco M; O'Sullivan C; Sheridan GK
Neuropharmacology; 2017 Feb; 113(Pt B):608-617. PubMed ID: 27059127
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid as the initiator of neuropathic pain.
Ueda H
Biol Pharm Bull; 2011; 34(8):1154-8. PubMed ID: 21804198
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidic Acid Receptor 1- and 3-Mediated Hyperalgesia and Hypoalgesia in Diabetic Neuropathic Pain Models in Mice.
Ueda H; Neyama H; Matsushita Y
Cells; 2020 Aug; 9(8):. PubMed ID: 32824296
[TBL] [Abstract][Full Text] [Related]
10. Loss of spinal substance P pain transmission under the condition of LPA1 receptor-mediated neuropathic pain.
Inoue M; Yamaguchi A; Kawakami M; Chun J; Ueda H
Mol Pain; 2006 Aug; 2():25. PubMed ID: 16914035
[TBL] [Abstract][Full Text] [Related]
11. Prostaglandin F2α FP receptor inhibitor reduces demyelination and motor dysfunction in a cuprizone-induced multiple sclerosis mouse model.
Iwasa K; Yamamoto S; Takahashi M; Suzuki S; Yagishita S; Awaji T; Maruyama K; Yoshikawa K
Prostaglandins Leukot Essent Fatty Acids; 2014 Nov; 91(5):175-82. PubMed ID: 25224839
[TBL] [Abstract][Full Text] [Related]
12. Modulation of chemoresistance by lysophosphatidic acid (LPA) signaling through LPA
Minami K; Ueda N; Maeda H; Ishimoto K; Otagaki S; Tsujiuchi T
Biochem Biophys Res Commun; 2019 Sep; 517(2):359-363. PubMed ID: 31362892
[TBL] [Abstract][Full Text] [Related]
13. Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
Azami Tameh A; Clarner T; Beyer C; Atlasi MA; Hassanzadeh G; Naderian H
Ann Anat; 2013 Oct; 195(5):415-23. PubMed ID: 23711509
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal monitoring of metabolic alterations in cuprizone mouse model of multiple sclerosis using 1H-magnetic resonance spectroscopy.
Orije J; Kara F; Guglielmetti C; Praet J; Van der Linden A; Ponsaerts P; Verhoye M
Neuroimage; 2015 Jul; 114():128-35. PubMed ID: 25871629
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine.
Nagai J; Uchida H; Matsushita Y; Yano R; Ueda M; Niwa M; Aoki J; Chun J; Ueda H
Mol Pain; 2010 Nov; 6():78. PubMed ID: 21062487
[TBL] [Abstract][Full Text] [Related]
16. LPA signaling is required for dopaminergic neuron development and is reduced through low expression of the LPA1 receptor in a 6-OHDA lesion model of Parkinson's disease.
Yang XY; Zhao EY; Zhuang WX; Sun FX; Han HL; Han HR; Lin ZJ; Pan ZF; Qu MH; Zeng XW; Ding Y
Neurol Sci; 2015 Nov; 36(11):2027-33. PubMed ID: 26169757
[TBL] [Abstract][Full Text] [Related]
17. LPA5 receptor plays a role in pain sensitivity, emotional exploration and reversal learning.
Callaerts-Vegh Z; Leo S; Vermaercke B; Meert T; D'Hooge R
Genes Brain Behav; 2012 Nov; 11(8):1009-19. PubMed ID: 23039190
[TBL] [Abstract][Full Text] [Related]
18. Expression of lysophosphatidic acid receptor 5 is necessary for the regulation of intestinal Na
Jenkin KA; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2018 Oct; 315(4):G433-G442. PubMed ID: 29792531
[TBL] [Abstract][Full Text] [Related]
19. 17β-Estradiol enhances the efficacy of adipose-derived mesenchymal stem cells on remyelination in mouse model of multiple sclerosis.
Ragerdi Kashani I; Hedayatpour A; Pasbakhsh P; Kafami L; Atlasi N; Pirhajati Mahabadi V; Mamoudi R; Baazm M
Acta Med Iran; 2012; 50(12):789-97. PubMed ID: 23456519
[TBL] [Abstract][Full Text] [Related]
20. LPA
Minami K; Ueda N; Ishimoto K; Tsujiuchi T
Exp Cell Res; 2020 Mar; 388(1):111813. PubMed ID: 31904382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
